Ensysce Biosciences Inc. (ENSC)
NASDAQ · Healthcare
Ensysce Biosciences Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 5.1M | 5.2M | 2.2M | 2.5M | 3.5M | 3.9M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -10.2M | -6.7M | -10.7M | -24.2M | -19.9M | -1.6M |
| EBITDA | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | 4.3M |
| Per Share Data | ||||||
| EPS (diluted) | $-3.98 | $-11.45 | $-70.40 | $-139.42 | $-1.48 | $0.00 |
| Shares Outstanding (dil.) | 3M | 1M | 0M | 0M | 20M | 17M |
Ensysce Biosciences Inc. Income Statement — FAQ
Ensysce Biosciences Inc. (ENSC) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENSC's income statement history?
The chart and table above show Ensysce Biosciences Inc.'s income statement by year and by quarter, including the growth rate.